Siena Salvatore
Full professor
SSD
MED/06 - MEDICAL ONCOLOGY
Competition sector
06/D3 - BLOOD DISEASES, ONCOLOGY AND RHEUMATOLOGY
Research fields and competencies
Contacts
Workplace
Additional phone numbers
University email address
E-mail
Office hours
by appointment +39 02 6444.2291
Office
Ospedale Niguarda, Piazza Ospedale Maggiore 3,Milano
Information on reception
Teaching - Programme courses
Bachelors and masters
A.Y. 2021/2022
A.Y. 2020/2021
A.Y. 2019/2020
A.Y. 2018/2019
A.Y. 2017/2018
Postgraduate programmes
A.Y. 2021/2022
2nd level vocational master
- Aspetti regolatori per l'avvio e la conduzione di trial clinici (Master in Artificial Intelligence and Machine Learning in Cancer Medicine - secondo livello)
- Ia nella medicina di precisione 2 (Master in Artificial Intelligence and Machine Learning in Cancer Medicine - secondo livello)
A.Y. 2020/2021
1st level vocational master
- Metodologia clinica oncologica (Master in management degli studi clinici in oncologia ed emato-oncologia - primo livello)
2nd level vocational master
- Patologia oncologica nel ciclo di vita (Master in Psiconcologia - II Livello)
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
- Neurochirurgia 2 (Postgraduate School of Neurosurgery)
A.Y. 2019/2020
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
- Medical oncology (Postgraduate School of Gynecology and Obstetrics)
- Neurochirurgia 2 (Postgraduate School of Neurosurgery)
- Oncologia medica (Postgraduate Specialization of Internal Medicine)
- Oncologia medica (Postgraduate School of General Surgery)
- Oncologia medica (Postrgraduate School of Geriatric Medicine)
- Oncologia medica (Postgraduate School of Hematology)
- Oncologia medica 1 (Postgraduate School of Medical Oncology)
- Oncologia medica 2 (Postgraduate School of Medical Oncology)
- Oncologia medica 3 (Postgraduate School of Medical Oncology)
- Oncologia medica 4 (Postgraduate School of Medical Oncology)
- Oncologia medica 5 (Postgraduate School of Medical Oncology)
- Oncologia medica tronco comune (Postgraduate School of Clinical Pharmacology and Toxicology)
- Oncologia medica tronco comune (Postgraduate School of Clinical Pharmacology and Toxicology Reserved For Non-Doctors)
A.Y. 2018/2019
1st level vocational master
- Metodologia clinica oncologica (Master in management degli studi clinici in oncologia ed emato-oncologia - primo livello)
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
- Medical oncology (Postgraduate School of Gynecology and Obstetrics)
- Neurochirurgia 2 (Postgraduate School of Neurosurgery)
- Oncologia medica (Postrgraduate School of Geriatric Medicine)
- Oncologia medica (Postgraduate School of Hematology)
- Oncologia medica (Postgraduate Specialization of Internal Medicine)
- Oncologia medica (Postgraduate School of General Surgery)
- Oncologia medica 1 (Postgraduate School of Medical Oncology)
- Oncologia medica 2 (Postgraduate School of Medical Oncology)
- Oncologia medica 3 (Postgraduate School of Medical Oncology)
- Oncologia medica 4 (Postgraduate School of Medical Oncology)
- Oncologia medica 5 (Postgraduate School of Medical Oncology)
- Oncologia medica tronco comune (Postgraduate School of Clinical Pharmacology and Toxicology)
- Oncologia medica tronco comune (Postgraduate School of Clinical Pharmacology and Toxicology Reserved For Non-Doctors)
Research
Publications
Publications
-
Empowering clinical decision making in oligometastatic colorectal cancer: The potential role of drug screening of patient-derived organoids / G. Mauri, E. Durinikova, A. Amatu, F. Tosi, A. Cassingena, F. Rizzetto, K. Buzo, P. Arcella, M.C. Aquilano, E. Bonoldi, S. Marsoni, S. Siena, A. Bardelli, A. Sartore Bianchi, S. Arena. - In: JCO PRECISION ONCOLOGY. - ISSN 2473-4284. - 5:5(2021 Jul), pp. 1192-1199. [10.1200/PO.21.00143]
-
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01) : a multicentre, open-label, phase 2 trial / S. Siena, M. Di Bartolomeo, K. Raghav, T. Masuishi, F. Loupakis, H. Kawakami, K. Yamaguchi, T. Nishina, M. Fakih, E. Elez, J. Rodriguez, F. Ciardiello, Y. Komatsu, T. Esaki, K. Chung, Z. Wainberg, A. Sartore-Bianchi, K. Saxena, E. Yamamoto, E. Bako, Y. Okuda, J. Shahidi, A. Grothey, T. Yoshino. - In: THE LANCET ONCOLOGY. - ISSN 1470-2045. - (2021 May 04). [Epub ahead of print] [10.1016/S1470-2045(21)00086-3]
-
Strategies to tackle RAS-mutated metastatic colorectal cancer / G. Patelli, F. Tosi, A. Amatu, G. Mauri, A. Curaba, D.A. Patane, A. Pani, F. Scaglione, S. Siena, A. Sartore Bianchi. - In: ESMO OPEN. - ISSN 2059-7029. - 6:3(2021 Jun), pp. 100156.1-100156.13. [10.1016/j.esmoop.2021.100156]
-
Mechanisms of immune escape and resistance to checkpoint inhibitor therapies in mismatch repair deficient metastatic colorectal cancers / V. Amodio, G. Mauri, N.M. Reilly, A. Sartore Bianchi, S. Siena, A. Bardelli, G. Germano. - In: CANCERS. - ISSN 2072-6694. - 13:11(2021 May), pp. 2638.1-2638.33. [10.3390/cancers13112638]
-
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA / G. Patelli, C. Vaghi, F. Tosi, G. Mauri, A. Amatu, D. Massihnia, S. Ghezzi, E. Bonazzina, K. Bencardino, G. Cerea, S. Siena, A. Sartore Bianchi. - In: TARGETED ONCOLOGY. - ISSN 1776-2596. - 16:3(2021 May), pp. 309-324. [10.1007/s11523-021-00795-5]